Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

A randomized trial of early endovenous ablation in venous ulceration

Tools
- Tools
+ Tools

Gohel, Manjit S., Heatley, Francine, Liu, Xinxue, Bradbury, Andrew, Bulbulia, Richard, Cullum, Nicky, Epstein, David M., Nyamekye, Isaac, Poskitt, Keith R., Renton, Sophie , Warwick, Jane and Davies, Alun H. (2018) A randomized trial of early endovenous ablation in venous ulceration. New England Journal Of Medicine , 378 . pp. 2105-2114. doi:10.1056/NEJMoa1801214 ISSN 0028-4793.

[img]
Preview
PDF
WRAP-randomized-trial-early-endovenous-Davies-2018.pdf - Published Version - Requires a PDF viewer.

Download (702Kb) | Preview
Official URL: http://dx.doi.org/10.1056/NEJMoa1801214

Request Changes to record.

Abstract

BACKGROUND
Venous disease is the most common cause of leg ulceration. Although compression therapy improves venous ulcer healing, it does not treat the underlying causes of venous hypertension. Treatment of superficial venous reflux has been shown to reduce the rate of ulcer recurrence, but the effect of early endovenous ablation of superficial venous reflux on ulcer healing remains unclear.

METHODS
In a trial conducted at 20 centers in the United Kingdom, we randomly assigned 450 patients with venous leg ulcers to receive compression therapy and undergo early endovenous ablation of superficial venous reflux within 2 weeks after randomization (early-intervention group) or to receive compression therapy alone, with consideration of endovenous ablation deferred until after the ulcer was healed or until 6 months after randomization if the ulcer was unhealed (deferred-intervention group). The primary outcome was the time to ulcer healing. Secondary outcomes were the rate of ulcer healing at 24 weeks, the rate of ulcer recurrence, the length of time free from ulcers (ulcer-free time) during the first year after randomization, and patient-reported health-related quality of life.

RESULTS
Patient and clinical characteristics at baseline were similar in the two treatment groups. The time to ulcer healing was shorter in the early-intervention group than in the deferred-intervention group; more patients had healed ulcers with early intervention (hazard ratio for ulcer healing, 1.38; 95% confidence interval [CI], 1.13 to 1.68; P=0.001). The median time to ulcer healing was 56 days (95% CI, 49 to 66) in the early-intervention group and 82 days (95% CI, 69 to 92) in the deferred-intervention group. The rate of ulcer healing at 24 weeks was 85.6% in the early-intervention group and 76.3% in the deferred-intervention group. The median ulcer-free time during the first year after trial enrollment was 306 days (interquartile range, 240 to 328) in the early-intervention group and 278 days (interquartile range, 175 to 324) in the deferred-intervention group (P=0.002). The most common procedural complications of endovenous ablation were pain and deep-vein thrombosis.

CONCLUSIONS
Early endovenous ablation of superficial venous reflux resulted in faster healing of venous leg ulcers and more time free from ulcers than deferred endovenous ablation.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH): Veins -- Diseases -- Treatment, Leg -- Ulcers -- Treatment, Clinical trials
Journal or Publication Title: New England Journal Of Medicine
Publisher: Massachusetts Medical Society
ISSN: 0028-4793
Official Date: 31 May 2018
Dates:
DateEvent
31 May 2018Published
24 April 2018Available
13 March 2018Accepted
Volume: 378
Page Range: pp. 2105-2114
DOI: 10.1056/NEJMoa1801214
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Date of first compliant deposit: 26 April 2018
Date of first compliant Open Access: 24 November 2018
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
Health Technology Assessment Program (11/129/197)National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us